Barbora Decker

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 7

Top Topics

Decision Making

Rheumatoid Arthritis Patients

Disease Activity

Top Venues

Expert review of gastroenterology & hepatology

International journal of technology assessment in health care

Applied health economics and health policy

This page only lists publications with an associated author ORCID identifier.

Publications

Barbora Decker, Tomas Mlcoch, Anastasie Pustovalova, Tomas Dolezal
Novel approach to decision making for orphan drugs. International journal of technology assessment in health care 39 (1) (2023)
Barbora Decker, Tomas Mlcoch, Anastasie Pustovalova, Tomas Dolezal
Novel approach to decision making for orphan drugs. International journal of technology assessment in health care 39 (1) (2023)
Barbora Decker, Jan Tuzil, Milan Lukas, Karin Cerna, Martin Bortlik, Barbora Velackova, Barbora Pilnackova, Tomas Dolezal
Patient-reported symptoms are a more reliable predictor of the societal burden compared to established physician-reported activity indices in inflammatory bowel disease: a cross-sectional study. Expert review of gastroenterology & hepatology 17 (1) (2022)
Barbora Decker, Jan Tuzil, Milan Lukas, Karin Cerna, Martin Bortlik, Barbora Velackova, Barbora Pilnackova, Tomas Dolezal
Patient-reported symptoms are a more reliable predictor of the societal burden compared to established physician-reported activity indices in inflammatory bowel disease: a cross-sectional study. Expert review of gastroenterology & hepatology 17 (1) (2022)
Barbora Decker, Jan Tuzil, Milan Lukas, Karin Cerna, Martin Bortlik, Barbora Velackova, Barbora Pilnackova, Tomas Dolezal
Patient-reported symptoms are a more reliable predictor of the societal burden compared to established physician-reported activity indices in inflammatory bowel disease: a cross-sectional study. Expert review of gastroenterology & hepatology (2022)
Barbora Decker, Jan Tuzil, Milan Lukas, Karin Cerna, Martin Bortlik, Barbora Velackova, Barbora Pilnackova, Tomas Dolezal
Patient-reported symptoms are a more reliable predictor of the societal burden compared to established physician-reported activity indices in inflammatory bowel disease: a cross-sectional study. Expert review of gastroenterology & hepatology (2022)
Tomas Mlcoch, Barbora Decker, Tomas Dolezal
Cost-Effectiveness Analysis of Parenteral Methotrexate for the Treatment of Crohn's Disease. Applied health economics and health policy 19 (4) (2021)